Charles A Peloquin (Charles Peloquin, C A Peloquin)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 47

Top Topics

Multidrug Resistant

Replacement Therapy

Hepatitis C Virus

Staphylococcus Aureus

Top Venues

Antimicrobial agents and chemotherapy

Open forum infectious diseases

Nature communications

Antibiotics (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Xueyi Chen, Bhavatharini Arun, Oscar J Nino-Meza, Mona O Sarhan, Medha Singh, Byeonghoon Jeon, Kishor Mane, Maunank Shah, Elizabeth W Tucker, Laurence S Carroll, Joel S Freundlich, Charles A Peloquin, Vijay D Ivaturi, Sanjay K Jain
Dynamic PET reveals compartmentalized brain and lung tissue antibiotic exposures of tuberculosis drugs. Nature communications 15 (1) (2024)
Jeffrey M Collins, Maia Kipiani, Yutong Jin, Ashish A Sharma, Jeffrey A Tomalka, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze, Shorena Sabanadze, Zaza Avaliani, Henry M Blumberg, David Benkeser, Dean P Jones, Charles A Peloquin, Russell R Kempker
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. medRxiv : the preprint server for health sciences (2023)
Alex Ashkin, Afe Alexis, Megan Ninneman, Rene Rico Tresgallo, David Ashkin, Charles A Peloquin
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring. Open forum infectious diseases 10 (6) (2023)
Alex Ashkin, Afe Alexis, Megan Ninneman, Rene Rico Tresgallo, David Ashkin, Charles A Peloquin
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring. Open forum infectious diseases 10 (6) (2023)
Yingda L Xie, Nisha Modi, Deborah Handler, Sijia Yu, Prakruti Rao, Leonid Kagan, Kristen Petros de Guex, Robert Reiss, Anna Siemiątkowska, Anshika Narang, Navaneeth Narayanan, Jasie Hearn, Amanda Khalil, Patricia Woods, Laura Young, Alfred Lardizabal, Selvakumar Subbian, Charles A Peloquin, Christopher Vinnard, Tania A Thomas, Scott K Heysell
Simplified urine-based method to detect rifampin underexposure in adults with tuberculosis: a prospective diagnostic accuracy study. Antimicrobial agents and chemotherapy (2023)
Nicole F Maranchick, Jessica Webber, Mohammad H Alshaer, Timothy W Felton, Charles A Peloquin
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Alex Ashkin, Afe Alexis, Megan Ninneman, Rene Rico Tresgallo, David Ashkin, Charles A Peloquin
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring. Open forum infectious diseases 10 (6) (2023)
Niklas Köhler, Hande Karaköse, Hans-Peter Grobbel, Doris Hillemann, Sönke Andres, Christina König, Barbara Kalsdorf, Thomas Theo Brehm, Laura Böttcher, Inna Friesen, Harald Hoffmann, Dražen Strelec, Dagmar Schaub, Charles A Peloquin, Stefan Schmiedel, Laurent A Decosterd, Eva Choong, Sebastian G Wicha, Rob E Aarnoutse, Christoph Lange, Patricia M Sánchez Carballo
A Single-Run HPLC-MS Multiplex Assay for Therapeutic Drug Monitoring of Relevant First- and Second-Line Antibiotics in the Treatment of Drug-Resistant Tuberculosis. Pharmaceutics 15 (11) (2023)
Jeffrey M Collins, Maia Kipiani, Yutong Jin, Ashish A Sharma, Jeffrey A Tomalka, Teona Avaliani, Mariam Gujabidze, Tinatin Bakuradze, Shorena Sabanadze, Zaza Avaliani, Henry M Blumberg, David Benkeser, Dean P Jones, Charles A Peloquin, Russell R Kempker
Pharmacometabolomics in TB Meningitis - understanding the pharmacokinetic, metabolic, and immune factors associated with anti-TB drug concentrations in cerebrospinal fluid. medRxiv : the preprint server for health sciences (2023)
Nicole F Maranchick, Jessica Webber, Mohammad H Alshaer, Timothy W Felton, Charles A Peloquin
Impact of Beta-Lactam Target Attainment on Resistance Development in Patients with Gram-Negative Infections. Antibiotics (Basel, Switzerland) 12 (12) (2023)
Alex Ashkin, Afe Alexis, Megan Ninneman, Rene Rico Tresgallo, David Ashkin, Charles A Peloquin
Concomitant Treatment of Tuberculosis and Hepatitis C Virus in Coinfected Patients Using Serum Drug Concentration Monitoring. Open forum infectious diseases 10 (6) (2023)
Daniel S Graciaa, Maia Kipiani, Matthew J Magee, Lali Mikiashvili, Ketevan Barbakadze, Nino Bablishvili, Sara C Auld, Wael A Alghamdi, Mohammad H Alshaer, Charles A Peloquin, Zaza Avaliani, Henry M Blumberg, Russell R Kempker
Linezolid Exposure Is Associated with Cytopenias in Patients Treated for Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 66 (9) (2022)
Walter M Yamada, Sarah Kim, Mohammed Almoslem, Soyoung Kim, Jenny Myrick, Jocelyn Nole, Brandon Duncanson, Arnold Louie, Charles A Peloquin, Stephan Schmidt, George L Drusano, Michael Noel Neely
Combination Therapy to Kill Mycobacterium tuberculosis in Its Nonreplicating Persister Phenotype. Antimicrobial agents and chemotherapy 66 (10) (2022)
Mohammad H Alshaer, Brooke Barlow, Nicole Maranchick, Miriam Moser, Leon Gramss, Heinz Burgmann, Valentin Al Jalali, Michael Wölfl-Duchek, Walter Jäger, Stefan Poschner, Walter Plöchl, Andrea Reinprecht, Karl Rössler, Andreas Gruber, Markus Zeitlinger, Charles A Peloquin, Arthur Hosmann
Meropenem Population Pharmacokinetics and Simulations in Plasma, Cerebrospinal Fluid, and Brain Tissue. Antimicrobial agents and chemotherapy 66 (8) (2022)
Mohammad H Alshaer, Nicole Maranchick, Chen Bai, Kelly L Maguigan, Bethany R Shoulders, Timothy W Felton, Sumith K Mathew, Mamoun T Mardini, Charles A Peloquin
Using Machine Learning To Define the Impact of Beta-Lactam Early and Cumulative Target Attainment on Outcomes in Intensive Care Unit Patients with Hospital-Acquired and Ventilator-Associated Pneumonia. Antimicrobial agents and chemotherapy 66 (7) (2022)
George L Drusano, Sarah Kim, Mohammed Almoslem, Stephan Schmidt, D Z D'Argenio, Jenny Myrick, Brandon Duncanson, Jocelyn Nole, David Brown, Charles A Peloquin, Michael Neely, Walter Yamada, Arnold Louie
The Funnel: a Screening Technique for Identifying Optimal Two-Drug Combination Chemotherapy Regimens. Antimicrobial agents and chemotherapy 65 (2) (2021)
George L Drusano, Stephanie Rogers, David Brown, Charles A Peloquin, Michael Neely, Walter Yamada, Sarah Kim, Mohammed Almoslem, Stephan Schmidt, Arnold Louie
Dose Fractionation of Moxifloxacin for Treatment of Tuberculosis: Impact of Dosing Interval and Elimination Half-Life on Microbial Kill and Resistance Suppression. Antimicrobial agents and chemotherapy 65 (4) (2021)
Mohammad H Alshaer, Kelly Maguigan, Jennifer Ashton, Veena Venugopalan, Molly E Droege, Carolyn Dosen Philpott, Christopher A Droege, Daniel P Healy, Eric W Mueller, Charles A Peloquin
Applying cefepime population pharmacokinetics on critically ill patients receiving continuous renal replacement therapy. Antimicrobial agents and chemotherapy (2021)
Oren Gordon, Donald E Lee, Bessie Liu, Brooke Langevin, Alvaro A Ordonez, Dustin A Dikeman, Babar Shafiq, John M Thompson, Paul D Sponseller, Kelly Flavahan, Martin A Lodge, Steven P Rowe, Robert F Dannals, Camilo A Ruiz-Bedoya, Timothy D Read, Charles A Peloquin, Nathan K Archer, Lloyd S Miller, Kimberly Michele Davis, Jogarao V S Gobburu, Sanjay K Jain
Dynamic PET-facilitated modeling and high-dose rifampin regimens for Staphylococcus aureus orthopedic implant-associated infections. Science translational medicine 13 (622) (2021)
Mohammad H Alshaer, Sylvain Goutelle, Barbara A Santevecchi, Bethany R Shoulders, Veena Venugopalan, Kartikeya Cherabuddi, Jiajun Liu, Patrick J Kiel, Jason Alexander Roberts, Fekade Bruck Sime, Marc H Scheetz, Michael N Neely, Charles A Peloquin
Cefepime Precision Dosing Tool: from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics. Antimicrobial agents and chemotherapy 66 (2) (2021)
Mohammad H Alshaer, Carolyn Dosen Philpott, Christopher A Droege, Joshua D Courter, Daniel P Healy, Molly E Droege, Neil E Ernst, Eric W Mueller, Charles A Peloquin
Cefepime Population Pharmacokinetics and Target Attainment in Critically Ill Patients on Continuous Renal Replacement Therapy. Antimicrobial agents and chemotherapy 65 (6) (2021)
Sarah Kim, Walter M Yamada, Brandon Duncanson, Jocelyn Nole, Stephanie Rogers, Sarah Parker, Meredith Bacci, Nino Mtchedlidze, Charles A Peloquin, Arnold Louie, Stephan Schmidt, George L Drusano, Michael Noel Neely
Building Optimal Three-Drug Combination Chemotherapy Regimens To Eradicate Mycobacterium tuberculosis in Its Slow-Growth Acid Phase. Antimicrobial agents and chemotherapy 65 (10) (2021)
Mohammad H Alshaer, Anne-Grete Märtson, Wael A Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Eric R Houpt, David Ashkin, David E Griffith, J Peter Cegielski, Scott K Heysell, Charles A Peloquin
Ethionamide Population Pharmacokinetic Model and Target Attainment in Multidrug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 64 (9) (2020)
Mohammad H Alshaer, Michael N Neely, Jiajun Liu, Kartikeya Cherabuddi, Veena Venugopalan, Nathaniel James Rhodes, Kenneth P Klinker, Marc H Scheetz, Charles A Peloquin
Population Pharmacokinetics and Target Attainment of Cefepime in Critically Ill Patients and Guidance for Initial Dosing. Antimicrobial agents and chemotherapy 64 (9) (2020)
Payam Nahid, Sundari R Mase, Giovanni Battista Migliori, Giovanni Sotgiu, Graham H Bothamley, Jan L Brozek, Adithya Cattamanchi, J Peter Cegielski, Lisa Chen, Charles L Daley, Tracy L Dalton, Raquel Duarte, Federica Fregonese, Charles R Horsburgh, Faiz Ahmad Khan, Fayez Kheir, Zhiyi Lan, Alfred A Lardizabal, Michael Lauzardo, Joan M Mangan, Suzanne M Marks, Lindsay McKenna, Dick Menzies, Carole D Mitnick, Diana M Nilsen, Farah Parvez, Charles A Peloquin, Ann Raftery, Pawel T Schubert, Neha S Shah, Jeffrey R Starke, John W Wilson, Jonathan M Wortham, Terence Chorba, Barbara Seaworth
Treatment of Drug-Resistant Tuberculosis. An Official ATS/CDC/ERS/IDSA Clinical Practice Guideline. American journal of respiratory and critical care medicine 200 (10) (2020)
G L Drusano, Michael N Neely, Sarah Kim, Walter M Yamada, Stephan Schmidt, Brandon Duncanson, Jocelyn Nole, Nino Mtchedlidze, Charles A Peloquin, Arnold Louie
Building Optimal Three-Drug Combination Chemotherapy Regimens. Antimicrobial agents and chemotherapy 64 (11) (2020)
George L Drusano, Brandon Duncanson, C A Scanga, Sarah Kim, S Schmidt, M N Neely, W M Yamada, Michael Vicchiarelli, Charles A Peloquin, Arnold Louie
Developing New Drugs for Mycobacterium tuberculosis Therapy: What Information Do We Get from Preclinical Animal Models? Antimicrobial agents and chemotherapy 64 (12) (2020)
Wael A Alghamdi, Mohammad H Alshaer, Kenneth P Klinker, Charles A Peloquin
Variable linezolid exposure and response and the role of therapeutic drug monitoring: Case series. Clinical case reports 8 (7) (2020)
Wael A Alghamdi, Mohammad H Alshaer, Guohua An, Abdullah Alsultan, Maia Kipiani, Ketevan Barbakadze, Lali Mikiashvili, David Ashkin, David E Griffith, J Peter Cegielski, Russell R Kempker, Charles A Peloquin
Population Pharmacokinetics of Linezolid in Tuberculosis Patients: Dosing Regimen Simulation and Target Attainment Analysis. Antimicrobial agents and chemotherapy 64 (10) (2020)
Wael A Alghamdi, Abdullah Alsultan, Mohammad H Alshaer, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, Stephan Schmidt, Scott K Heysell, Russell R Kempker, J Peter Cegielski, Charles A Peloquin
Cycloserine Population Pharmacokinetics and Pharmacodynamics in Patients with Tuberculosis. Antimicrobial agents and chemotherapy 63 (5) (2019)
Mohammad H Alshaer, Wael A Alghamdi, Abdullah Alsultan, Guohua An, Shahriar Ahmed, Yosra Alkabab, Sayera Banu, Ketevan Barbakadze, Eric Houpt, Maia Kipiani, Lali Mikiashvili, J Peter Cegielski, Russell R Kempker, Scott K Heysell, Charles A Peloquin
Fluoroquinolones in Drug-Resistant Tuberculosis: Culture Conversion and Pharmacokinetic/Pharmacodynamic Target Attainment To Guide Dose Selection. Antimicrobial agents and chemotherapy 63 (7) (2019)
Amyn A Malik, Meredith B Brooks, Sara Siddiqui, Junaid Fuad, Charles A Peloquin, Farhana Amanullah, Maria Jaswal, Mercedes C Becerra, Hamidah Hussain, Courtney M Yuen
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis. Antimicrobial agents and chemotherapy 63 (5) (2019)
Russell R Kempker, Wael A Alghamdi, Mohammad H Alshaer, Gena Burch, Charles A Peloquin
A Pharmacology Perspective of Simultaneous Tuberculosis and Hepatitis C Treatment. Antimicrobial agents and chemotherapy (2019)
Anthony Enimil, Sampson Antwi, Hongmei Yang, Albert Dompreh, Wael A Alghamdi, Fizza S Gillani, Antoinette Orstin, Dennis Bosomtwe, Theresa Opoku, Jennifer Norman, Lubbe Wiesner, Taimour Langaee, Charles A Peloquin, Michael H Court, David J Greenblatt, Awewura Kwara
Effect of First-Line Antituberculosis Therapy on Nevirapine Pharmacokinetics in Children Younger than Three Years Old. Antimicrobial agents and chemotherapy 63 (10) (2019)
Simone H J van den Elsen, Marieke G G Sturkenboom, Onno W Akkerman, Katerina Manika, Ioannis P Kioumis, Tjip S van der Werf, John L Johnson, Charles A Peloquin, Daan J Touw, Jan-Willem C Alffenaar
Limited Sampling Strategies Using Linear Regression and the Bayesian Approach for Therapeutic Drug Monitoring of Moxifloxacin in Tuberculosis Patients. Antimicrobial agents and chemotherapy 63 (7) (2019)
Elizabeth W Tucker, Lisa Pieterse, Matthew D Zimmerman, Zarir F Udwadia, Charles A Peloquin, Maria Tarcela Gler, Shashank Ganatra, Jeffrey A Tornheim, Prerna Chawla, Janice C Caoili, Brittaney Ritchie, Sanjay K Jain, Veronique Anne Dartois, Kelly E Dooley
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans. Antimicrobial agents and chemotherapy 63 (10) (2019)
Sara H Browne, Anya Umlauf, Amanda J Tucker, Julie Low, Kathleen Moser, Jonathan Gonzalez Garcia, Charles A Peloquin, Terrence Blaschke, Florin Vaida, Constance A Benson
Wirelessly observed therapy compared to directly observed therapy to confirm and support tuberculosis treatment adherence: A randomized controlled trial. PLoS medicine 16 (10) (2019)
Awewura Kwara, Hongmei Yang, Sampson Antwi, Anthony Enimil, Fizza S Gillani, Albert Dompreh, Antoinette Ortsin, Theresa Opoku, Dennis Bosomtwe, Anima Sarfo, Lubbe Wiesner, Jennifer Norman, Wael A Alghamdi, Taimour Langaee, Charles A Peloquin, Michael H Court, David J Greenblatt
Effect of Rifampin-Isoniazid-Containing Antituberculosis Therapy on Efavirenz Pharmacokinetics in HIV-Infected Children 3 to 14 Years Old. Antimicrobial agents and chemotherapy 63 (1) (2018)
G L Drusano, Jenny Myrick, Michael Maynard, Jocelyn Nole, Brandon Duncanson, David Brown, Stephan Schmidt, Michael Neely, C A Scanga, Charles A Peloquin, Arnold Louie
Linezolid Kills Acid-Phase and Nonreplicative-Persister-Phase Mycobacterium tuberculosis in a Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 62 (8) (2018)
Simone H J van den Elsen, Marieke G G Sturkenboom, Natasha Van't Boveneind-Vrubleuskaya, Alena Skrahina, Tjip S van der Werf, Scott K Heysell, Stellah Mpagama, Giovanni B Migliori, Charles A Peloquin, Daan J Touw, Jan-Willem C Alffenaar
Population Pharmacokinetic Model and Limited Sampling Strategies for Personalized Dosing of Levofloxacin in Tuberculosis Patients. Antimicrobial agents and chemotherapy 62 (12) (2018)
Wael A Alghamdi, Mohammad H Alshaer, Charles A Peloquin
Protein Binding of First-Line Antituberculosis Drugs. Antimicrobial agents and chemotherapy 62 (7) (2018)
Yasuhiro Horita, Abdullah Alsultan, Awewura Kwara, Sampson Antwi, Antony Enimil, Antoinette Ortsin, Albert Dompreh, Hongmei Yang, Lubbe Wiesner, Charles A Peloquin
Evaluation of the Adequacy of WHO Revised Dosages of the First-Line Antituberculosis Drugs in Children with Tuberculosis Using Population Pharmacokinetic Modeling and Simulations. Antimicrobial agents and chemotherapy 62 (9) (2018)
Arnold Louie, Brandon Duncanson, Jenny Myrick, Michael Maynard, Jocelyn Nole, David Brown, Stephan Schmidt, Michael Neely, C A Scanga, Charles A Peloquin, G L Drusano
Activity of Moxifloxacin against Mycobacterium tuberculosis in Acid Phase and Nonreplicative-Persister Phenotype Phase in a Hollow-Fiber Infection Model. Antimicrobial agents and chemotherapy 62 (12) (2018)
Charles A Peloquin, Patrick P J Phillips, Carole D Mitnick, Kathleen Eisenach, Ramonde F Patientia, Leonid Lecca, Eduardo Gotuzzo, Neel R Gandhi, Donna Butler, Andreas H Diacon, Bruno Martel, Juan Santillan, Kathleen Robergeau Hunt, Dante Vargas, Florian von Groote-Bidlingmaier, Carlos Seas, Nancy Dianis, Antonio Moreno-Martinez, Pawandeep Kaur, C Robert Horsburgh
Increased Doses Lead to Higher Drug Exposures of Levofloxacin for Treatment of Tuberculosis. Antimicrobial agents and chemotherapy 62 (10) (2018)